Teva Pharma (TEVA) PT Raised to $15 at Argus
Get Alerts TEVA Hot Sheet
Price: $32.83 -0.76%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Argus analyst Jasper Hellweg raised the price target on Teva Pharma (NYSE: TEVA) to $15.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Resonac Holdings Corp (4004:JP) (SHWDY) PT Raised to JPY23,000 at Nomura/Instinet
- Tokio Marine Holdings, Inc (8766:JP) (TKOMY) PT Lowered to JPY8,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share